Abstract

Significant regulatory and legal changes in the field of veterinary pharmacy have been taking place since 2019. The federal law and by-laws have regulated many pain points of the industry: the import of medicines for the treatment of rare animals, the absence of prescription forms of the established order, the sale of substances directly to livestock farms, the frequency of reporting, the renewal of the license for medicinal preparations, the examination of drugs, the activities of veterinary pharmacy organizations have been streamlined. These changes, of course, have become the impetus for the development of the veterinary medicines market.However, the problem of interaction with the markets of other countries, including those belonging to the Eurasian Economic Union, is significant and especially aggravated in the current conditions. Regulation of the industry in partner countries, as a rule, is based on other standards, which poses a threat to the Russian market at a new stage, which, in the conditions of active implementation of the new model, simultaneously is a subject to geopolitical changes. In such a situation, the authorized bodies will have to maintain the achieved level of regulation and find opportunities to support domestic producers.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call